Cara Therapeutics, Inc. Company Profile

07:47 EDT 2nd September 2014 | BioPortfolio

News Articles [26 Associated News Articles listed on BioPortfolio]

Cara Therapeutics' (CARA) CEO Derek Chalmers on Q2 2014 Results - Earnings Call Transcript

Cara Therapeutics, Inc. (NASDAQ:CARA) Q2 2014 Results Earnings Conference Call August 07, 2014, 04:30 PM ET Executives Jesse Baumgartner - Stern Investor Relations, Inc. Derek Chalmers - President...

Cara Therapeutics doses first patient in Phase Ia/Ib trial of CR845 to treat acute, chronic pain

Enteris BioPharma, an industry leader in innovative oral dosage formulations, has announced that its development partner, Cara Therapeutics (CARA) has dosed the first subjects in a further Phase 1a/1b...

Cara Therapeutics Readies Novel Analgesic For Phase III In Acute Pain

Having just completed an IPO netting nearly $59 million, Cara is seeking an end-of-Phase II meeting with FDA to design registrational trials for CR845, an intravenous selective kappa opioid receptor a...

Cara Therapeutics begins Phase Ia/Ib trial of tablet formulation of oral pain drug CR845

US-based biopharmaceutical firm Cara Therapeutics has started dosing first subjects in a Phase Ia/Ib clinical trial of an oral tablet formulation of its peripherally-selective kappa opioid agonist, CR...

Cara Therapeutics begins Phase II trial of kappa opioid agonist to treat uremic pruritus

US-based biopharmaceutical firm Cara Therapeutics has dosed the first dialysis patients in a Phase II trial of an intravenous (IV) formulation of its peripherally selective kappa opioid agonist, CR845...

Cara management update

Cara Therapeutics Reports First Quarter 2014 Financial Results

SHELTON, Conn., May 12, 2014 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq:CARA), a biopharmaceutical company focused on developing and commercializing new chemical entities designed to allevia...

Cara Therapeutics Reports Second Quarter 2014 Financial Results

SHELTON, Conn., Aug. 7, 2014 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq:CARA), a biopharmaceutical company focused on developing and commercializing new chemical entities designed to allevia...

PubMed Articles [2 Associated PubMed Articles listed on BioPortfolio]

Label-free chemiluminescent aptasensor for platelet-derived growth factor detection based on exonuclease-assisted cascade autocatalytic recycling amplification.

Here an exonuclease III (Exo III)-assisted cascade autocatalytic recycling amplification (Exo-CARA) strategy is proposed for label-free chemiluminescent (CL) detection of platelet-derived growth facto...

Identification of human trafficking victims in dental care settings.

Trafficking in human beings (THB) is a modern form of slavery and is a well-known phenomenon throughout the European Union and beyond. After drug dealing and the weapons industry, human trafficking is...

Clinical Trials [1 Associated Clinical Trials listed on BioPortfolio]

Protecting the 'Hood Against Tobacco

Among all racial/ethnic groups, African Americans have the greatest risk of becoming ill or dying from tobacco-related diseases. Because of this disproportionate disease burden, it is part...

Companies [4 Associated Companies listed on BioPortfolio]

CARA Therapeutics

Cara possesses both near-term clinical development opportunities, combined with proprietary approaches to developing first-in-class novel therapeutics. Cara's first patented compound, CR665, has enter...

Cara Therapeutics, Inc.


Instituto de Cirugía Maxilofacial e Implantología

Me es grato darles la bienvenida a la página web del INSTITUTO DE CIRUGIA MAXILOFACIAL E IMPLANTOLOGIA.El Instituto, fundado en Mayo del 2000, tiene como objetivo el tratamiento integral médico-quir...

More Information about "Cara Therapeutics, Inc." on BioPortfolio

We have published hundreds of Cara Therapeutics, Inc. news stories on BioPortfolio along with dozens of Cara Therapeutics, Inc. Clinical Trials and PubMed Articles about Cara Therapeutics, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Cara Therapeutics, Inc. Companies in our database. You can also find out about relevant Cara Therapeutics, Inc. Drugs and Medications on this site too.

Search BioPortfolio:

Corporate Database Quicklinks

Searches Linking to this Company Record